ArticleJournal of Cancer2023

miR-134-3p driven by anisomycin impairs ovarian cancer stem cell activity through inhibiting GPR137 expression.

Lele Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.